Insider trade

Wave Life Sciences (WVE)Director sold ~$85K

Christian O Henry, Director at Wave Life Sciences, sold ~$85K of Wave Life Sciences shares.

~$85K
Approx. value · 9,670 sh @ $8.81
30K
Holds after · shares reported
Traded
Aug 13, 2025
Filed
Aug 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 13, 2025InsiderDirector sold ~$209K of WVE shares in the open market
  2. Aug 5, 2025Insider · 2 peopleInsiders: 2 sales (~$52K)
  3. Aug 13, 2025 · this disclosureInsiderDirector sold ~$85K of WVE shares in the open market

What came next

  1. Aug 15, 2025InsiderDirector sold ~$194K of WVE shares in the open market
  2. Aug 22, 2025Insider · 2 peopleInsiders: 2 sales (~$2.3M)
  3. Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
  4. Dec 9, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Wave Life Sciences

OQRO holds no insider, Congress, fund or contract record for Wave Life Sciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its WVE page.

Other recent filings by Christian O Henry, Director

The full history of Christian O Henry, Director is on the profile page.

How this filing works

Other disclosures at Wave Life Sciences

Everything OQRO holds on this company is on its WVE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data